Insurance almost never covers sermorelin. The sermorelin sold today is a compounded drug, and the rules plans follow are written around approved drug products, which no sermorelin product now is.
That history is in is sermorelin FDA approved, and the route to a prescription is in sermorelin prescription.
$185
Typical month of sermorelin, cash (137 sellers)
$99
Lowest published month
$349
Highest published month
$2,220
A year at the typical price
Those are cash prices, read through September 2026. They are what most buyers pay, because the coverage routes below rarely open.
Why Medicare Part D does not pay for it
Part D defines a covered drug by reference to Medicaid’s definition of a covered outpatient drug[2]. That definition centers on drugs approved for safety and effectiveness under the FD&C Act, or approved as generics[3].
For compounds, CMS’s Part D manual is specific. Only the costs of the ingredients that meet the Part D drug definition are allowable, because a compounded product as a whole does not meet it[1]. A compound can hold all, some or none of those ingredients[1].
Sermorelin’s approved products were GEREF, and FDA withdrew both approvals effective June 2009, after the maker discontinued them[4]. With no approved sermorelin product, a compounded vial has little or nothing in it that a Part D plan can count.
Private plans and the formulary problem
Commercial plans set their own formularies, and their terms vary. The common thread is the one FDA states plainly: compounded drugs are not FDA-approved, and FDA does not verify their safety, effectiveness or quality before they are sold[5]. That status is the usual reason a plan leaves them off.
So the honest answer for a private plan is to ask it. Request the answer in writing, naming the drug as compounded sermorelin, and ask whether a prior authorization or an exception process exists. The wider picture is in the insurance guide.
HSA and FSA: a different question
A health savings account is not insurance, and its test is different. IRS Publication 502 lets you count amounts paid for prescribed medicines and drugs, meaning drugs that require a prescription[6]. Lab fees that are part of medical care count too[6].
The limit is purpose. Medical care must be primarily to alleviate or prevent a physical or mental illness, not merely beneficial to general health[6]. How that applies to peptides, and what to keep as a record, is in can you use an HSA for peptides. The same test applied to an NAD+ drip is in does insurance cover NAD IV therapy.
What to budget instead
Plan on the cash price, plus any lab work the program asks for. What an IGF-1 test costs is in IGF-1 blood test, and a month from start to finish is in the sermorelin cost guide.
The question to ask your plan is narrow on purpose: does it cover compounded sermorelin, and if not, will it say so in writing? A written answer settles the question before the first charge, not after it.